发明名称 Aqueous solubility pharmaceutical formulations
摘要 A formulation of a sparingly water-soluble, crystalline pharmaceutically active agent wherein the active agent is converted to and stabilized in its amorphous form as a solid solution of a normally hydrophobic vehicle is described. The amorphous state is stabilized by the composition of the formulation, providing long shelf life of the improved composition. This stabilized formulation also provides increased solubility and bioavailability of the active agent. Solutions of the active agent are stabilized by the composition, preventing recrystallization and precipitation of the less soluble, crystalline form of the active agent from aqueous solutions thereof.
申请公布号 US6497905(B1) 申请公布日期 2002.12.24
申请号 US20000528624 申请日期 2000.03.20
申请人 R.P. SCHERER TECHNOLOGIES, INC. 发明人 VLADYKA, JR. RONALD S.;ERKOBONI DAVID F.;STERGIOS PAMELA R.
分类号 A61K47/38;A01N43/50;A01N45/00;A61K;A61K9/14;A61K9/16;A61K9/48;A61K31/415;A61K31/496;A61K31/56;A61K47/04;A61K47/08;A61K47/10;A61K47/14;A61K47/32;A61K47/34;A61K47/36;A61K47/42;A61K47/44;A61P31/10;C07D293/00;C07D421/00;C07D517/00;C07D521/00;(IPC1-7):A61K9/16;A61K47/26;A61K31/419;A61K31/357 主分类号 A61K47/38
代理机构 代理人
主权项
地址